促销时间表 IMV Inc.
先进的时间表
简单图表
关于公司 IMV Inc.
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. 更多详情Industry | Biotechnology |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.imv-inc.com |
Цена ао | 0.0001 |
每日价格变化: | 0% (0.0001) |
---|---|
每周价格变化: | 0% (0.0001) |
每月价格变化: | 0% (0.0001) |
3个月内价格变化: | 0% (0.0001) |
六个月内的价格变化: | 0% (0.0001) |
每年价格变化: | 0% (0.0001) |
3年内价格变化: | -100% (15) |
5年内价格变化: | -100% (21.8) |
年初以来价格变化: | 0% (0.0001) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Andrew Hall M.Sc. | CEO & Director | 680.6k | |
Ms. Brittany Davison C.A., CPA | Chief Accounting Officer, Corporate Secretary & Director | 207.9k | 1990 (35 年) |
Delphine Davan | Senior Director of Communications & Investor Relations | N/A | |
Mr. Stephan Fiset M.B.A., M.Sc. | Vice President of Clinical Research | N/A | |
Dr. Jeremy R. Graff Ph.D. | Chief Scientific Officer | 1971 (54 年) |
地址: Canada, Dartmouth. NS BB C, 130 Eileen Stubbs Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.imv-inc.com
网站: https://www.imv-inc.com